Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal sepsis: the potential for immunotherapy.

J E Baley1

  • 1Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio.

Clinics in Perinatology
|December 1, 1988
PubMed
Summary

Immunotherapy shows promise for treating neonatal sepsis, a condition with high mortality. While intravenous immunoglobulin has yielded encouraging results, further research is essential before widespread clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants.

The Journal of pediatrics·1994
Same author

Neonatal candidiasis: the current challenge.

Clinics in perinatology·1991
Same author

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.

The Journal of pediatrics·1990
Same author

Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow.

The Journal of laboratory and clinical medicine·1990
Same author

Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infants.

The Journal of pediatrics·1989
Same author

Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study.

The Journal of pediatrics·1989

Area of Science:

  • Neonatal immunology
  • Infectious diseases

Background:

  • Neonatal sepsis remains a leading cause of mortality in newborns worldwide.
  • Current treatment strategies have limitations, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

  • To explore the potential of immunotherapy, specifically intravenous immunoglobulin, for treating neonatal sepsis.
  • To review existing data on the efficacy and safety of immunotherapy in this vulnerable population.

Main Methods:

  • Review of current literature on immunotherapy for neonatal sepsis.
  • Analysis of outcomes from studies involving intravenous immunoglobulin.

Main Results:

  • Immunotherapy, particularly with intravenous immunoglobulin, has demonstrated encouraging preliminary outcomes in neonatal sepsis.
  • Existing studies suggest a potential benefit, but data are limited.

Conclusions:

  • Immunotherapy holds significant promise as a future treatment modality for neonatal sepsis.
  • Substantial additional research and clinical data are required to establish its safety and efficacy for widespread clinical application.

Related Experiment Videos